TEL-AVIV, Israel, October 17 /PRNewswire-FirstCall/ -- TopSpin Medical (TASE: TOPMD), the developer of a unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, announced today the appointment of Cindy Setum, Ph.D., as Vice President, Clinical Affairs.
Dr. Setum has over 15 years of experience in cardiovascular research in the medical device industry. She has a Ph.D. from the University of Minnesota, holds several medical device patents and has published extensively in the areas of cardiologic, peripheral and neurovascular applications for interventional medical devices. Dr. Setum was previously Vice President of Clinical and Medical Affairs at Possis Medical, Inc., where for 12 years she supervised preclinical and clinical research in catheter-based thrombectomy (removal of intravascular blood clots).
Yaron Tal, TopSpin's CEO, commented: "The addition of Dr. Setum to our management team as Vice President of Clinical Affairs is a significant step in building our global presence in the Cardiology market. Dr. Setum's track record of accomplishments and strong medical device background make her well suited for this position. She has the leadership skills and expertise to move our clinical research program forward."
TopSpin Medical developed an innovative and unique technology for high-resolution MRI using an IntraVascular MRI (IVMRI) catheter for the coronary arteries, without the need for an expensive and bulky external MRI setup. The catheter contains those components, which are usually found in a conventional MRI scanner, only that they are miniaturized to less than 2 millimeters in size. In 2006 TopSpin Medical began to develop its technology for imaging prostate cancer by an integrated endo-rectal MRI and ultrasound probe.
STATEMENTS IN THIS PRESS RELEASE WHICH ARE NOT HISTORICAL DATA ARE FORWARD-LOOKING STATEMENTS WHICH INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES OR OTHER FACTORS NOT UNDER THE COMPANY'S CONTROL, WHICH MAY CAUSE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF THE COMPANY TO BE MATERIALLY DIFFERENT FROM THE RESULTS, PERFORMANCE OR OTHER EXPECTATIONS IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. THESE FACTORS INCLUDE, BUT ARE NOT LIMITED TO, THOSE DETAILED IN THE COMPANY'S PERIODIC FILINGS WITH THE SECURITIES AUTHORITIES.
- Caution: TopSpin IVMRI system is not available for sale in the United States.
CONTACT: Contact: Eyal Kolka, CFO & Senior Vice President, Business
Development, +972-8-920-0033, firstname.lastname@example.org